Table 4.
Mean MLHFQ Scores and EQ-5D Scores for SA-NYHA Groups (ALL Patients and SELF-assessed Patients) at Baseline and at 6 Months' Follow-up
| SA-NYHA I/II |
SA-NYHA III |
SA-NYHA IV |
|||||
|---|---|---|---|---|---|---|---|
| Mean Score (SD) | No. of Respondents | Mean Score (SD) | No. of Respondents | Mean Score (SD) | No. of Respondents | P Value | |
| ALL patients | |||||||
| MLHFQ at 6 months∗ | 29.1 (19.5) | 56 | 50.9 (28.4) | 51 | 60.0 (23.0) | 51 | P = .002† |
| EQ-5D at 6 months‡ | 0.60 (0.32) | 91 | 0.38 (0.36) | 90 | 0.34 (0.35) | 87 | P = .047† |
| SELF patients | |||||||
| MLHFQ at 6 months∗ | 28.9 (20.7) | 32 | 49.8 (28.4) | 32 | 62.2 (22.5) | 25 | P < .0001† |
| EQ-5D at 6 months‡ | 0.61 (0.33) | 51 | 0.37 (0.35) | 50 | 0.35 (0.35) | 42 | P = .11† |
MLHFQ, Minnesota Living with Heart Failure Questionnaire; EQ-5D; SA-NYHA: self-assigned New York Heart Association.
∗
Low scores imply better health.
†
Analysis of variance adjusted for baseline differences.
‡
High scores imply better health.